Molecubes Modular Benchtop Preclinical PET Imaging System

Molecubes Modular Benchtop Preclinical PET Imaging System

Catalog Number:
LARE506017SIN
Mfr. No.:
SIN240037AM
Price:
  • Size:
    EA
    Quantity:
    Add to Cart:
      • Overview
        • Sub-millimeter image resolution is achieved through the combination of monolithic scintillators, the latest photon counting technology and GPU-based event positioning, and iterative image reconstruction.
          The 5-ring configuration ensures best-in-class sensitivity over a field of view that is adequate for whole-body mouse and rat imaging at a high count rate.
          In-house hardware enables dynamic and gated studies. Intuitive, wireless acquisition software, combined with our multimodal small-animal bed, enables easy and modular multimodal imaging when used along with the γ-CUBE (SPECT) and X-CUBE (CT).

          Product Principles
          Positron Emission Tomography (PET)
          PET is a tomography imaging device specially used for the experimental study of small animals in vivo. Compared with the clinical PET system, the spatial resolution and sensitivity of the system are higher than that of the clinical PET system, so as to adapt to the requirements of the study of small animal models. PET principle is: The developer (such as fluorodeoxyglucose, FDG) labeled with short decay period radionuclides (such as 18F, 11C, 15O, etc.), injected into the organism, releases positrons during the decay process, and a positron annihilates after encountering an electron after traveling a few tenths of a millimeter to a few millimeters. This produces a pair of high-energy gamma photons of 511KeV energy in opposite directions (180 degrees). This pair of photons is captured by a highly sensitive camera and then scattered by a computer and corrected for random information. By doing the same analysis on different positrons, we can get a three-dimensional image of how the developer accumulates in the organism. PET is the only new imaging technology that can display biomolecular metabolism, receptor and neuromediator activities in vivo, and has been widely used in the diagnosis and differential diagnosis of a variety of diseases, disease judgment, efficacy evaluation, organ function research and new drug development. It has the characteristics of high sensitivity, high specificity, whole body imaging and good safety.

          Product Characteristics
          · Highest Throughput – Fast and sensitive/low dose
          · High-end Performance – PET/CT and SPECT/CT without compromise
          · Compact – light and mobile
          · Ease of use – functional and straight-forward
          · Best Uptime in preclinical industry
          · Fast workflow
          Thanks to our fast and simple CUBEFLOW and intuitive user interfaces, 3D images are obtained using a turnkeysolution.
          · High precision
          Extremely high-quality imaging in terms of resolution and precision and field of view at the smallest footprint.
          · Modular
          Our CUBES are designed to work bothas stand-alone units and in modular combinations so you can optimize yourworkflow and increase throughput.
          · Benchtop
          MOLECUBES offers exquisite whole body mouse and rat imaging while fitting on top of any classic lab bench.
          · Best uptime
          98.6% System uptime and a dedicated support team with extensive preclinical imaging expertise.
          · User friendly
          Developed by end users, we pride ourselves in our intuitive software that allows even the most novice users tocapture beautiful images.

          Please contact us at for specific academic pricing.

      • Properties
      • Applications
        • Application Description
          Oncology research: tumor genesis, metabolism, apoptosis, lymphatic vessel imaging, hypoxia imaging, tumor receptor research, tumor gene imaging, tumor treatment evaluation, etc.;
          Research on neurological diseases: brain perfusion imaging, brain receptor imaging, brain metabolism imaging, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), inflammatory molecular imaging, etc.;
          Cardiovascular system disease research: heart disease (coronary heart disease, heart failure, heart transplant evaluation), atherosclerosis, thrombosis, cardiac nerve receptor research, etc.;
          Gene therapy imaging: molecular imaging evaluation of gene therapy;
          Cell tracer technology: stem cell therapy, all kinds of diseases (nervous system diseases, myocardial infarction, etc.) after cell therapy evaluation;
          New drug research and development: preclinical experiments (biological distribution, pharmacokinetics), drug target confirmation, drug lead compound screening;
          Others: bone disease research, infectious disease research, metabolic disease research, etc.

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
    Copyright © Amerigo Scientific. All rights reserved.